NCT03099668 is a NA clinical trial of Visit to a multidisciplinary clinic in Rheumatoid Arthritis, sponsored by National University Hospital, Singapore.

Who is sponsoring NCT03099668?

NCT03099668 is sponsored by National University Hospital, Singapore.

What drugs are being tested in NCT03099668?

Interventions in NCT03099668: Visit to a multidisciplinary clinic.

What condition does NCT03099668 study?

NCT03099668 studies Rheumatoid Arthritis, Multidisciplinary Communication.

Is NCT03099668 still recruiting?

NCT03099668 is currently completed. Last updated 27 September 2021.

Last reviewed 2021-09-27 · How we verify

NCT03099668

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multidisciplinary Team Care in Rheumatoid Arthritis

Completed NA Last updated 27 September 2021

What this trial tests

NA trial testing Visit to a multidisciplinary clinic in Rheumatoid Arthritis in 140 participants. Completed in 28 February 2019.

Timeline

17 November 2016

Primary endpoint
17 May 2018

28 February 2019

Quick facts

Lead sponsor	National University Hospital, Singapore
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	140
Start date	17 November 2016
Primary completion	17 May 2018
Estimated completion	28 February 2019
Sites	1 location across Singapore

Drugs / interventions tested

Visit to a multidisciplinary clinic

Conditions studied

Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
Multidisciplinary Communication — all drugs for Multidisciplinary Communication →

Sponsor

National University Hospital, Singapore

Who can join

21 and older, any sex, with Rheumatoid Arthritis or Multidisciplinary Communication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomised study of multidisciplinary care (MDT) versus routine care in patients with rheumatoid arthritis (RA). Patients with RA are randomised either to a single visit to a "one Stop Arthritis Clinic' (OSAC) or to see their usual rheumatologists. Data are collected at the baseline visit, and again at subsequent clinic visits (approximately 3 and 6 months). Outcomes such as quality of life, disease activity, physical function, disease specific knowledge, coping and self efficacy are evaluated. Assessment of comorbidities and preventative care (cancer screening, vaccinations, cardiovascular risk assessment and optimisation) are also assessed between the 2 arms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Evaluation of a multidisciplinary care model to improve quality of life in rheumatoid arthritis: a randomised controlled trial.
Lahiri M, Cheung PPM, Dhanasekaran P, Wong SR, et al · · 2022 · cited 17× · PMID 34741249 · DOI 10.1007/s11136-021-03029-3

Verify or expand the search:

Other recruiting trials for Rheumatoid Arthritis

Currently open trials in the same condition.

NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting

Other National University Hospital, Singapore trials

Trials by the same sponsor.

NCT06027983 — Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors · Phase 1, PHASE2 · not yet recruiting
NCT07460505 — Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure · NA · not yet recruiting
NCT07319676 — Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas · Phase 1, PHASE2 · recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
NCT07091175 — Dupilumab Therapy in Nephrotic Syndrome in Children · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03099668 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National University Hospital, Singapore
Last refreshed: 27 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03099668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing